Transcription of COPYRIGHTED MATERIAL- DO NOT COPY OR DISTRIBUTE
{{id}} {{{paragraph}}}
COPYRIGHTED MATERIAL- DO NOT COPY OR DISTRIBUTE ii GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018 REPORT) 2018 Global Initiative for Chronic Obstructive Lung Disease, Inc. COPYRIGHTED MATERIAL- DO NOT COPY OR DISTRIBUTE GOLD BOARD OF DIRECTORS (2017) GOLD SCIENCE COMMITTEE* (2017) Alvar Agusti, MD, Chair Respiratory Institute, Hospital Clinic, IDIBAPS Univ. Barcelona and Ciberes Barcelona, Spain Bartolome R. Celli, MD Brigham and Women s Hospital Boston, Massachusetts, USA Rongchang Chen, MD Guangzhou Institute of Respiratory Disease Guangzhou, PRC Gerard Criner, MD Temple University School of Medicine Philadelphia, Pennsylvania, USA Peter Frith, MD Repatriation General Hospital, Adelaide, South Australia, Australia David Halpin, MD Royal Devon and Exeter Hospital Devon, UK M. Victorina L pez Varela, MD Universidad de la Rep blica Montevideo, Uruguay Masaharu Nishimura, MD Hokkaido University School of Medicine Sapporo, Japan Claus Vogelmeier, MD University of Marburg Marburg, Germany Claus Vogelmeier, MD, Chair University of Marburg Marburg, Germany Alvar Agusti, MD Respiratory Institute, Hospital Clinic, IDIBAPS Univ.
Basel, Switzerland SYRIA. Yousser Mohammad, MD. Lattakia, Syria TURKEY. Professor Ali Kocabas, MD. ... future risk of exacerbations, the extent of airflow limitation, the spirometric ... The separation of airflow limitation from clinical parameters makes it clearer what is being evaluated and ranked. This revised assessment tool
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}